ZA200400313B - Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine. - Google Patents
Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine.Info
- Publication number
- ZA200400313B ZA200400313B ZA200400313A ZA200400313A ZA200400313B ZA 200400313 B ZA200400313 B ZA 200400313B ZA 200400313 A ZA200400313 A ZA 200400313A ZA 200400313 A ZA200400313 A ZA 200400313A ZA 200400313 B ZA200400313 B ZA 200400313B
- Authority
- ZA
- South Africa
- Prior art keywords
- bibn4096
- migraine
- treatment
- combination
- antimigraine drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10139410A DE10139410A1 (de) | 2001-08-17 | 2001-08-17 | Verwendung von BIBN4096 in Kombination mit anderen Arzneistoffen gegen Migräne für die Behandlung von Migräne |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200400313B true ZA200400313B (en) | 2004-11-01 |
Family
ID=7695082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200400313A ZA200400313B (en) | 2001-08-17 | 2004-01-15 | Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine. |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1420790B1 (xx) |
JP (1) | JP2005503382A (xx) |
KR (1) | KR20040027892A (xx) |
CN (1) | CN1543347A (xx) |
AR (1) | AR036265A1 (xx) |
AT (1) | ATE304854T1 (xx) |
BR (1) | BR0211970A (xx) |
CA (1) | CA2454083A1 (xx) |
CO (1) | CO5560577A2 (xx) |
DE (2) | DE10139410A1 (xx) |
EA (1) | EA200400253A1 (xx) |
EC (1) | ECSP044979A (xx) |
ES (1) | ES2250733T3 (xx) |
HR (1) | HRP20040150A2 (xx) |
HU (1) | HUP0401484A3 (xx) |
IL (1) | IL159879A0 (xx) |
MX (1) | MXPA04001364A (xx) |
NO (1) | NO20041024D0 (xx) |
PL (1) | PL365482A1 (xx) |
UY (1) | UY27416A1 (xx) |
WO (1) | WO2003015787A1 (xx) |
ZA (1) | ZA200400313B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8465468B1 (en) | 2000-06-29 | 2013-06-18 | Becton, Dickinson And Company | Intradermal delivery of substances |
DE10207026A1 (de) * | 2002-02-20 | 2003-08-28 | Boehringer Ingelheim Kg | Pulverinhalativum, enthaltend den CGRP-Antagonisten BIBN4096 und Verfahren zu dessen Herstellung |
EP1374870A1 (en) * | 2002-06-24 | 2004-01-02 | Rita Dobmeyer | Medication for the treatment or prevention of migraine |
DE10314617A1 (de) * | 2003-04-01 | 2004-10-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung des Hydrochlorids der Wirkstoffbase 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]-carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin in Kombination mit Sumatriptan zur Behandlung von Migräne |
DE10338399A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Mikropartikel, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-Iysyl]-4-(4-pyridinyl)-piperazin, Verfahren zu deren Herstellung sowie deren Verwendung als Inhalaltionspulver |
DE10338402A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknetes, amorphes BIBN 4096, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
DE10338407A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Inhalationspulver enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin |
DE10338403A1 (de) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
US20050065094A1 (en) | 2003-09-05 | 2005-03-24 | Boehringer Ingelheim International Gmbh | Use of telmisartan for the prevention and treatment of vascular headache |
CA2563687A1 (en) * | 2004-04-20 | 2005-11-03 | Boehringer Ingelheim International Gmbh | Use of a cgrp-antagonist combined with a serotonin-reuptake inhibitor in order to treat migraines |
US20050256182A1 (en) * | 2004-05-11 | 2005-11-17 | Sutter Diane E | Formulations of anti-pain agents and methods of using the same |
DE102004063753A1 (de) * | 2004-12-29 | 2006-07-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung ausgewählter CGRP-Antagonisten in Kombination mit anderen Arzneistoffen gegen Migräne für die Behandlung von Migräne |
CN102526031A (zh) * | 2010-12-27 | 2012-07-04 | 湖南九典制药有限公司 | 一种鼻腔内使用的舒马普坦药物组合物及其制备方法 |
CN103385876B (zh) * | 2012-05-08 | 2016-01-13 | 四川滇虹医药开发有限公司 | 一种夫罗曲坦的药物组合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR199900537T2 (xx) * | 1996-09-10 | 1999-07-21 | Dr. Karl Thomae Gmbh | D�n��t�r�lm�� amino asitler, bunlar� i�eren farmas�tik preparatlar. |
DE19937304C2 (de) * | 1999-08-10 | 2003-08-21 | Boehringer Ingelheim Pharma | Verwendung von CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen |
-
2001
- 2001-08-17 DE DE10139410A patent/DE10139410A1/de not_active Withdrawn
-
2002
- 2002-08-10 MX MXPA04001364A patent/MXPA04001364A/es unknown
- 2002-08-10 PL PL02365482A patent/PL365482A1/xx not_active Application Discontinuation
- 2002-08-10 CN CNA028161327A patent/CN1543347A/zh active Pending
- 2002-08-10 HU HU0401484A patent/HUP0401484A3/hu unknown
- 2002-08-10 CA CA002454083A patent/CA2454083A1/en not_active Abandoned
- 2002-08-10 AT AT02794772T patent/ATE304854T1/de not_active IP Right Cessation
- 2002-08-10 WO PCT/EP2002/008993 patent/WO2003015787A1/en active IP Right Grant
- 2002-08-10 BR BR0211970-6A patent/BR0211970A/pt active Pending
- 2002-08-10 KR KR10-2004-7002356A patent/KR20040027892A/ko not_active Application Discontinuation
- 2002-08-10 EA EA200400253A patent/EA200400253A1/ru unknown
- 2002-08-10 DE DE60206289T patent/DE60206289T2/de not_active Expired - Fee Related
- 2002-08-10 ES ES02794772T patent/ES2250733T3/es not_active Expired - Lifetime
- 2002-08-10 IL IL15987902A patent/IL159879A0/xx unknown
- 2002-08-10 EP EP02794772A patent/EP1420790B1/en not_active Expired - Lifetime
- 2002-08-10 JP JP2003520746A patent/JP2005503382A/ja active Pending
- 2002-08-14 UY UY27416A patent/UY27416A1/es not_active Application Discontinuation
- 2002-08-16 AR ARP020103101A patent/AR036265A1/es not_active Suspension/Interruption
-
2004
- 2004-01-15 ZA ZA200400313A patent/ZA200400313B/xx unknown
- 2004-02-12 CO CO04012009A patent/CO5560577A2/es not_active Application Discontinuation
- 2004-02-16 HR HR20040150A patent/HRP20040150A2/hr not_active Application Discontinuation
- 2004-02-16 NO NO20041024A patent/NO20041024D0/no not_active Application Discontinuation
- 2004-02-16 EC EC2004004979A patent/ECSP044979A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP044979A (es) | 2004-04-28 |
MXPA04001364A (es) | 2004-05-27 |
CN1543347A (zh) | 2004-11-03 |
DE10139410A1 (de) | 2003-02-27 |
KR20040027892A (ko) | 2004-04-01 |
DE60206289D1 (de) | 2006-02-02 |
AR036265A1 (es) | 2004-08-25 |
EP1420790B1 (en) | 2005-09-21 |
HUP0401484A3 (en) | 2007-03-28 |
IL159879A0 (en) | 2004-06-20 |
NO20041024D0 (no) | 2004-02-16 |
EP1420790A1 (en) | 2004-05-26 |
ATE304854T1 (de) | 2005-10-15 |
CA2454083A1 (en) | 2003-02-27 |
BR0211970A (pt) | 2004-09-21 |
PL365482A1 (en) | 2005-01-10 |
JP2005503382A (ja) | 2005-02-03 |
HUP0401484A2 (hu) | 2004-12-28 |
WO2003015787A1 (en) | 2003-02-27 |
EA200400253A1 (ru) | 2004-08-26 |
HRP20040150A2 (en) | 2004-06-30 |
ES2250733T3 (es) | 2006-04-16 |
UY27416A1 (es) | 2003-03-31 |
CO5560577A2 (es) | 2005-09-30 |
DE60206289T2 (de) | 2006-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
GB0109537D0 (en) | Well treatment fluids and methods for the use thereof | |
ZA200207650B (en) | Absorbent structure and absorbent articles containing the absorbent structure. | |
PT1757606E (pt) | Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação | |
GB0109414D0 (en) | Well treatment fluids and methods for the use thereof | |
AP2004003002A0 (en) | azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease. | |
IL174994A0 (en) | Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy | |
IL178402A0 (en) | 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof | |
HK1072443A1 (en) | Immunoconjugates for the treatment of tumours | |
ZA200703876B (en) | 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof | |
AP2006003537A0 (en) | Use of polypeptides of the cupredoxin family in cancer therapy. | |
MXPA03008739A (es) | Anticuerpos recombinantes asociados a gangliosidos. su uso en el diagnostico y tratamiento de tumores. | |
HK1051690A1 (en) | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain. | |
ZA200501288B (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma. | |
ZA200400313B (en) | Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine. | |
ZA200003236B (en) | Combination therapy for the treatment of migraine. | |
ZA200307475B (en) | Carbamate compounds for use in the treatment of pain. | |
AP2005003362A0 (en) | Formulation and methods for the treatment of thrombocythemia. | |
ZA200210316B (en) | Composition and its therapeutic use. | |
EG24959A (en) | Indoles useful in the treatment of androgenreceptor related diseases. | |
PL370272A1 (en) | Absorbent structure, and absorbent article containing the absorbent structure | |
MXPA03006099A (es) | Articulo absorbente con agente de tratamiento fluido. | |
TWI365187B (en) | 7-azaindoles and the use thereof as therapeutic agents | |
IL160722A0 (en) | Aryloxypropylamines as chemosensitizing agents in the treatment of cancer | |
MXPA03008393A (es) | Derivados de guanidina biciclicos y usos terapeuticos de los mismos. |